Latest California Healthline Stories
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
This Facebook Live discussion explores an aspect of the health care cost continuum that often flies below the radar.
Dialysis companies have contributed more than $104 million to defeat an initiative on California’s Nov. 6 ballot that would limit their profits — and are on the cusp of breaking the $109 million record set by the pharmaceutical industry in 2016.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Rebecca Adams of CQ Roll Call, Stephanie Armour of The Wall Street Journal and Joanne Kenen of Politico discuss how protections for people with preexisting conditions have become a top issue in the elections, Trump administration efforts to make prescription drug prices more public and the start of Medicare’s annual open-enrollment period. Plus, Rovner interviews California Attorney General Xavier Becerra.
Insurance companies profit from government contracts but are subject to little oversight of how they spend the money or care for patients. The expansion of Medicaid under the Affordable Care Act has only exacerbated the problem.
Nearly three-quarters of voters say that health care is the most important issue for them, but fewer than half are hearing much from candidates about it, according to a poll released by the Kaiser Family Foundation.
Federal health officials are investigating 127 cases of the disease, called acute flaccid myelitis, or AFM.
As rates of sexually transmitted diseases surge, public health officials want primary care doctors to step up screening and treatment of patients.
Seema Verma, who heads the Centers for Medicare & Medicaid Services, tells private insurance officials that a push by some Democrats to expand Medicare would only increase troubles the program already faces.
The decision aimed at adding folic acid — a vitamin that can prevent devastating neural tube defects — to flours, chips and tortillas hasn’t caught on with many makers of widely used corn products.